MedPath

Continuous Glucose Monitoring in Prediabetes

Not Applicable
Completed
Conditions
Pre-diabetes
Interventions
Device: The continuous glucose monitoring system
Registration Number
NCT06472297
Lead Sponsor
University of Southern California
Brief Summary

The objective of this project is to develop a behavioral intervention that combines wearable continuous glucose monitoring (CGM) with smartphone feedback and educational video clips generated by artificial intelligence (AI) software to improve glycemic control among individuals with pre-diabetes. The goal is to prevent transition to type 2 diabetes.

Detailed Description

Video narratives will be provided by Latino community health workers, known as Promotores de Salud (PdS), who will wear and experience the continuous glucose monitoring (CGM) system and its glycemic variability feedback. Study 1 (G1) is a Phase 0 intervention development study, enrolling a sample of 20 Spanish- and/or English-speaking PdS who test positive for pre-diabetes via a finger prick screening. Participants will wear CGM devices for 20 days, during which they will record daily narratives about their experiences with the CGM feedback and their glucose variability. Structured interviews between staff and participants will explore the benefits and barriers of CGM use. These recorded video clips will serve as the foundation for educational cinematic smartphone videos for future interventions. Artificial intelligence (AI) tools will be used to translate the text, audio, and video clips into various languages for broad dissemination. Blood glucose levels in mg/dL will be recorded continuously over the wear period.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
21
Inclusion Criteria
  • Prediabetes by finger prick blood A1C%
  • Willingness to wear CGM sensor
  • Latino community health worker
Exclusion Criteria
  • Currently pregnant
  • Less than 18 years of age, which is adult in California
  • Diagnosed with any disorder that interferes with glucose
  • Influential medical disorder/event affecting ability to participate in study
  • Incompatible smartphone device not pairing with Dexcom G6 app

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Unmasked CGM feedbackThe continuous glucose monitoring systemThe CGM system is used by the participant according to manufacturer instructions for the condition interval in their normal living environment.
Primary Outcome Measures
NameTimeMethod
Glucose levelsmaximum of 20 days of continuous wear

Mean glucose in mg/dL with glucose variability

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Southern California Center for Latino Health SCCLH

🇺🇸

Los Angeles, California, United States

© Copyright 2025. All Rights Reserved by MedPath